• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

饮食诱导的肥胖和胰岛素抵抗会促进吉田肉瘤大鼠的肿瘤生长和癌症恶病质。

Diet-induced obesity and insulin resistance spur tumor growth and cancer cachexia in rats bearing the Yoshida sarcoma.

作者信息

Honors Mary Ann, Kinzig Kimberly P

机构信息

a Department of Psychological Sciences and Ingestive Behavior Research Center , Purdue University , West Lafayette , Indiana , USA.

出版信息

Nutr Cancer. 2014;66(5):872-8. doi: 10.1080/01635581.2014.916325. Epub 2014 Jun 4.

DOI:10.1080/01635581.2014.916325
PMID:24897498
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4573561/
Abstract

Obesity and insulin resistance are associated with increased risk of cancer and cancer mortality. However, it is currently unknown whether they contribute to the development of cancer cachexia, a syndrome that contributes significantly to morbidity and mortality in individuals with cancer. The present experiment addresses the question of whether preexisting obesity and insulin resistance alter tumor growth and cancer cachexia symptoms in Yoshida sarcoma bearing male rats. Obesity and insulin resistance were induced through 5 weeks of high-fat (HF) diet feeding and insulin resistance was confirmed by intraperitoneal glucose tolerance testing. Chow-fed animals were used as a control group. Following the establishment of insulin resistance, HF- and chow-fed animals were implanted with fragments of the Yoshida sarcoma or received a sham surgery. Tumor growth rate was greater in HF-fed animals, resulting in larger tumors. In addition, cancer cachexia symptoms developed in HF-fed animals but not chow-fed animals during the 18-day experiment. These results support a stimulatory effect of obesity and insulin resistance on tumor growth and cancer cachexia development in Yoshida sarcoma-bearing rats. Future research should investigate the relationship between obesity, insulin resistance, and cancer cachexia in human subjects.

摘要

肥胖和胰岛素抵抗与癌症风险及癌症死亡率增加相关。然而,目前尚不清楚它们是否会导致癌症恶病质的发生,癌症恶病质是一种对癌症患者的发病率和死亡率有显著影响的综合征。本实验探讨了预先存在的肥胖和胰岛素抵抗是否会改变吉田肉瘤雄性大鼠的肿瘤生长和癌症恶病质症状。通过5周的高脂(HF)饮食喂养诱导肥胖和胰岛素抵抗,并通过腹腔葡萄糖耐量试验确认胰岛素抵抗。以普通饲料喂养的动物作为对照组。在建立胰岛素抵抗后,给高脂喂养和普通饲料喂养的动物植入吉田肉瘤组织块或进行假手术。高脂喂养动物的肿瘤生长速度更快,导致肿瘤更大。此外,在为期18天的实验中,高脂喂养动物出现了癌症恶病质症状,而普通饲料喂养动物未出现。这些结果支持肥胖和胰岛素抵抗对携带吉田肉瘤大鼠的肿瘤生长和癌症恶病质发展具有促进作用。未来的研究应调查肥胖、胰岛素抵抗和癌症恶病质在人类受试者中的关系。

相似文献

1
Diet-induced obesity and insulin resistance spur tumor growth and cancer cachexia in rats bearing the Yoshida sarcoma.饮食诱导的肥胖和胰岛素抵抗会促进吉田肉瘤大鼠的肿瘤生长和癌症恶病质。
Nutr Cancer. 2014;66(5):872-8. doi: 10.1080/01635581.2014.916325. Epub 2014 Jun 4.
2
Characterization of the Yoshida sarcoma: a model of cancer cachexia.描述 Yoshida 肉瘤:癌症恶病质模型。
Support Care Cancer. 2013 Oct;21(10):2687-94. doi: 10.1007/s00520-013-1839-y. Epub 2013 May 21.
3
Chronic exendin-4 treatment prevents the development of cancer cachexia symptoms in male rats bearing the Yoshida sarcoma.慢性 exendin-4 治疗可预防雄性 Yoshida 肉瘤荷瘤大鼠癌症恶病质症状的发展。
Horm Cancer. 2014 Feb;5(1):33-41. doi: 10.1007/s12672-013-0163-9. Epub 2013 Oct 8.
4
Characterization of the resistance to the anorectic and endocrine effects of leptin in obesity-prone and obesity-resistant rats fed a high-fat diet.高脂饮食喂养的肥胖倾向和肥胖抵抗大鼠对瘦素厌食和内分泌作用的抗性特征
J Endocrinol. 2004 Nov;183(2):289-98. doi: 10.1677/joe.1.05819.
5
Postprandial glucagon-like peptide-1 secretion is increased during the progression of glucose intolerance and obesity in high-fat/high-sucrose diet-fed rats.在高脂/高糖饮食喂养的大鼠中,随着葡萄糖耐量异常和肥胖的进展,餐后胰高血糖素样肽-1分泌增加。
Br J Nutr. 2015 May 14;113(9):1477-88. doi: 10.1017/S0007114515000550. Epub 2015 Apr 1.
6
[Establishment of high-fat diet-induced obesity and insulin resistance model in rats].[高脂饮食诱导大鼠肥胖及胰岛素抵抗模型的建立]
Beijing Da Xue Xue Bao Yi Xue Ban. 2020 Jun 18;52(3):557-563. doi: 10.19723/j.issn.1671-167X.2020.03.024.
7
Insulin Production and Resistance in Different Models of Diet-Induced Obesity and Metabolic Syndrome.不同饮食诱导肥胖和代谢综合征模型中的胰岛素生成与抵抗
Int J Mol Sci. 2017 Jan 28;18(2):285. doi: 10.3390/ijms18020285.
8
Early postweaning exercise improves central leptin sensitivity in offspring of rat dams fed high-fat diet during pregnancy and lactation.孕哺期高脂肪饮食导致母鼠后代,早期离乳后运动可改善其中枢瘦素敏感性。
Am J Physiol Regul Integr Comp Physiol. 2013 Nov 1;305(9):R1076-84. doi: 10.1152/ajpregu.00566.2012. Epub 2013 Sep 11.
9
Botryosphaeran, a (1 → 3)(1 → 6)-β-D-glucan, reduces tumor development and cachexia syndrome in obese male rats by increasing insulin sensitivity and FOXO3a activity.瓶梗孢葡聚糖(1→3)(1→6)-β-D-葡聚糖通过增加胰岛素敏感性和 FOXO3a 活性来减少肥胖雄性大鼠的肿瘤发生和恶病质综合征。
Int J Biol Macromol. 2020 Dec 15;165(Pt A):985-994. doi: 10.1016/j.ijbiomac.2020.09.168. Epub 2020 Sep 28.
10
JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses high fat diet-induced obesity and glucose intolerance in Sprague-Dawley rats.JTT-130,一种新型的微粒体甘油三酯转移蛋白肠道特异性抑制剂,可抑制高脂肪饮食诱导的肥胖和 Sprague-Dawley 大鼠的葡萄糖不耐受。
Diabetes Obes Metab. 2011 May;13(5):446-54. doi: 10.1111/j.1463-1326.2011.01368.x. Epub 2011 Jan 21.

引用本文的文献

1
as a Model System to Study Nonautonomous Mechanisms Affecting Tumour Growth and Cell Death.作为研究影响肿瘤生长和细胞死亡的非自主机制的模型系统。
Biomed Res Int. 2018 Mar 13;2018:7152962. doi: 10.1155/2018/7152962. eCollection 2018.
2
Obesity Does Not Exacerbate the Protumorigenic Systemic Environment in Sarcoma Subjects.肥胖不会加剧肉瘤患者的促肿瘤全身环境。
Immunohorizons. 2017 Jun 1;1(4):20-28. doi: 10.4049/immunohorizons.1700001. Epub 2017 Jun 5.

本文引用的文献

1
Characterization of the Yoshida sarcoma: a model of cancer cachexia.描述 Yoshida 肉瘤:癌症恶病质模型。
Support Care Cancer. 2013 Oct;21(10):2687-94. doi: 10.1007/s00520-013-1839-y. Epub 2013 May 21.
2
Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index.肥胖时代的癌症恶病质:骨骼肌消耗是一个强大的预后因素,与体重指数无关。
J Clin Oncol. 2013 Apr 20;31(12):1539-47. doi: 10.1200/JCO.2012.45.2722. Epub 2013 Mar 25.
3
Understanding the mechanisms and treatment options in cancer cachexia.了解癌症恶病质的发生机制和治疗选择。
Nat Rev Clin Oncol. 2013 Feb;10(2):90-9. doi: 10.1038/nrclinonc.2012.209. Epub 2012 Dec 4.
4
Clinical outcomes and contributors to weight loss in a cancer cachexia clinic.癌症恶病质诊所的临床结局和体重减轻的影响因素。
J Palliat Med. 2011 Sep;14(9):1004-8. doi: 10.1089/jpm.2011.0098. Epub 2011 Jul 27.
5
Cachexia as a major underestimated and unmet medical need: facts and numbers.恶病质是一种严重被低估且未得到满足的医疗需求:事实与数据。
J Cachexia Sarcopenia Muscle. 2010 Sep;1(1):1-5. doi: 10.1007/s13539-010-0002-6. Epub 2010 Oct 26.
6
Metformin reduces the stimulatory effect of obesity on in vivo Walker-256 tumor development and increases the area of tumor necrosis.二甲双胍可降低肥胖对 Walker-256 肿瘤体内生长的刺激作用,并增加肿瘤坏死面积。
Life Sci. 2011 May 9;88(19-20):846-52. doi: 10.1016/j.lfs.2011.03.005. Epub 2011 Mar 31.
7
Cancer cachexia: a systematic literature review of items and domains associated with involuntary weight loss in cancer.癌症恶病质:与癌症相关的非自愿性体重减轻有关的项目和领域的系统文献综述。
Crit Rev Oncol Hematol. 2011 Oct;80(1):114-44. doi: 10.1016/j.critrevonc.2010.10.004. Epub 2011 Jan 8.
8
Associations of insulin resistance and adiponectin with mortality in women with breast cancer.胰岛素抵抗和脂联素与乳腺癌女性死亡率的相关性。
J Clin Oncol. 2011 Jan 1;29(1):32-9. doi: 10.1200/JCO.2009.26.4473. Epub 2010 Nov 29.
9
Diabetes and cancer: a consensus report.糖尿病与癌症:共识报告。
CA Cancer J Clin. 2010 Jul-Aug;60(4):207-21. doi: 10.3322/caac.20078. Epub 2010 Jun 16.
10
Insulin resistance and cancer: epidemiological evidence.胰岛素抵抗与癌症:流行病学证据。
Cancer Sci. 2010 May;101(5):1073-9. doi: 10.1111/j.1349-7006.2010.01521.x. Epub 2010 Feb 3.